Abstract:Background: Interferon-gamma (IFN-γ), commonly referred to as type II interferon, is a crucial cytokine that coordinates the tumor immune process and has received considerable attention in tumor immunotherapy research. Previous studies have discussed the role and mechanisms associated with IFN-γ in specific tumors or diseases, but the relevant role of IFN-γ in pan-cancer remains uncertain. Methods: TCGA and GTEx RNA expression data and clinical data were downloaded. Additionally, we analyzed the role of IFN-γ on tumors by using a bioinformatic approach, which included the analysis of the correlation between IFN-γ in different tumors and expression, prognosis, functional status, TMB, MSI, immune cell infiltration, and TIDE. We also developed a PPI network for topological analysis of the network, identifying hub genes as those having a degree greater than IFN-γ levels. Result: IFN-γ was differentially expressed and predicted different survival statuses in a majority of tumor types in TCGA. Additionally, IFN-γ expression was strongly linked to factors like infiltration of T cells, immune checkpoints, immune-activating genes, immunosuppressive genes, chemokines, and chemokine receptors, as well as tumor purity, functional statuses, and prognostic value. Also, prognosis, CNV, and treatment response were all substantially correlated with IFN-γ-related gene expression. Particularly, the IFN-γ-related gene STAT1 exhibited the greatest percentage of SNVs and the largest percentage of SNPs in UCEC. Elevated expression levels of IFN-γ-related genes were found in a wide variety of tumor types, and this was shown to be positively linked to drug sensitivity for 20 different types of drugs. Conclusion: IFN-γ is a good indicator of response to tumor immunotherapy and is likely to limit tumor progression, offering a novel approach for immunotherapy's future development.

Double-edged Roles of IFNγ in Tumor Elimination and Immune Escape

Dual role of interferons in tumor immunology

Interferon Gamma in Cancer Immunotherapy

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

Double-edged Effects of Interferons on the Regulation of Cancer-Immunity Cycle

Roles of IFN-γ in tumor progression and regression: a review

The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion

Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy

Cancer Cell Resistance to IFNγ Can Occur Via Enhanced Double-Strand Break Repair Pathway Activity.

A Dual Role of Type I Interferons in Antitumor Immunity

Tumor Immune Checkpoints and Their Associated Inhibitors

The role of cancer-derived microRNAs in cancer immune escape

IFN-γ Mediates CD4+ T-cell Loss and Impairs Secondary Antitumor Responses after Successful Initial Immunotherapy

Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research

Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

Intratumoral Injection of Interferon Gamma Promotes the Efficacy of Anti-Pd1 Treatment in Colorectal Cancer

Immune Evasion and Therapeutic Opportunities Based on Natural Killer Cells.

Low-dose IFN-γ induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer

Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer

Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy.

Interferon-γ: teammate or opponent in the tumour microenvironment?